Medical Research News

RSS

Alteration in gut microbiome may lead to hyperinflammation in severe COVID-19

A team of international scientists has recently identified a distinct set of proinflammatory mediators and metabolites associated with the fatal consequences of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Moreover, they have established a link between gut microbiome alteration and hyper-inflammatory response in patients with severe COVID-19. The study is currently available on the bioRxiv* preprint server.

1 Nov 2021

Emerging SARS-CoV-2 variant A.30 efficiently evades vaccine-induced immunity

A recent study published in the journal Cellular & Molecular Immunology shows that a new A.30 variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can evade vaccine-induced antibodies and might spread outside the lungs extraordinarily well, with important implications for our public health response.

1 Nov 2021

Study shows COVID vaccination highly protective against death, especially for older age groups

Researchers from the UK used EAVE II, an individual-level, national surveillance system, to determine the frequency of COVID-19-related fatalities among fully vaccinated individuals and to define the clinical and demographic characteristics of COVID-19 deaths in fully vaccinated individuals since the beginning of the COVID-19 vaccination program in Scotland.

1 Nov 2021

Pregnant and breastfeeding women's perceptions and concerns about COVID-19 vaccines

Although severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination is one of the most important ways of fighting the ongoing COVID-19 pandemic, the recommendations for vaccination for pregnant and breastfeeding women are not consistent.

1 Nov 2021

Large U.S. study finds majority of mRNA COVID-19 side effects are mild and temporary

A new study posted to the medRxiv* preprint server, analyzed safety data from over 298 million mRNA COVID-19 vaccines administered in the first six months after the U.S. began its vaccination campaign.

1 Nov 2021

Neurological complications are higher with SARS-CoV-2 infection than COVID vaccine, study finds

Research published in the journal Nature Medicine suggests a risk for neurological complications after the first shot of a COVID-19 vaccine. However, the likelihood of developing neurological complications remains far greater among people infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

31 Oct 2021

Areas with higher 1968 influenza pandemic mortality have lower COVID-19 deaths

A new study demonstrates the influence of prior infectious outbreaks in a large population on succeeding pandemic outcomes.

31 Oct 2021

The impact of SARS-CoV-2 variants on the COVID-19 epidemic in South Africa

A new study explores the role of new SARS-CoV-2 variants in sustaining the pandemic in South Africa.

31 Oct 2021

Clinical assay validation for SARS-CoV-2 sequencing using Swift Biosciences amplicon panel

The current study used the guidelines of the FDA to validate the one-tube SARS-CoV-2 Swift Normalase Amplicon Panel Version 2.0 from Swift Biosciences.

31 Oct 2021

New Canadian serology solution for SARS-CoV-2 infections and vaccination

A new study developed a “Made-in-Canada” solution for enabling scalable and reproducible SARS-CoV-2 serology.

31 Oct 2021

COVID-19 patients' eyes and tears can be infected with SARS-CoV-2

A new study investigates the presence of SARS-CoV-2 in tears and eye secretions and describes the ocular symptoms in patients with COVID-19.

31 Oct 2021

Exercises using virtual reality to relieve COVID breathlessness

A recent study evaluates an immersive virtual reality-based digital intervention to alleviate refractory breathlessness in patients recovering from COVID-19.

31 Oct 2021

The ability of natural flavonoids to inhibit SARS-CoV-2

A recent systematic review discusses naturally occurring flavonoids as a promising antiviral alternative against SARS-CoV-2.

31 Oct 2021

Stanford neuromodulation therapy causes remission in almost 80% of patients with severe depression

A new type of magnetic brain stimulation brought rapid remission to almost 80% of participants with severe depression in a study conducted at the Stanford University School of Medicine.

30 Oct 2021

Researchers receive $9.1 million grant to study resilience in older adults before and during the pandemic

The National Institute on Aging of the National Institutes of Health has awarded researchers at Washington University School of Medicine in St. Louis a five-year, $9.1 million grant to study resilience in older adults before and during the COVID-19 pandemic, as well as the pandemic's cognitive and emotional effects on older adults.

30 Oct 2021

U of U Health scientists lead new studies investigating the long-term effects of COVID-19

University of Utah Health scientists are on the leading edge of a pair of large studies investigating the long-term effects of COVID-19.

30 Oct 2021

Opening schools for in-person learning not linked with increase in COVID-19 case rates

Since March 2020, parents, educators, and politicians have debated whether to send children to school in person during the COVID-19 pandemic.

30 Oct 2021

Children and adults have similar risks of SARS-CoV-2 infection, but kids do not show symptoms

New research addresses the misconception that children are less susceptible to infection with the new coronavirus.

30 Oct 2021

Researchers explore whether salivary glands infected with SARS-CoV-2 can diminish long-term immunity

University of Utah Health scientists are leading an effort to determine if salivary glands infected with the virus that causes COVID-19 could diminish a person’s long-term immunity to the disease after being immunized or after recovering from the illness.

30 Oct 2021

Moderna vaccine offers substantial protection against delta variant in vaccinated prisoners

When the delta variant of the coronavirus hit the Sierra Conservation Center — a low- to medium-security prison for men in California — residents who had received the Moderna vaccine were well protected against symptomatic infection, according to Stanford-led research.

30 Oct 2021

Medical Research News

Alteration in gut microbiome may lead to hyperinflammation in severe COVID-19

Emerging SARS-CoV-2 variant A.30 efficiently evades vaccine-induced immunity

Study shows COVID vaccination highly protective against death, especially for older age groups

Pregnant and breastfeeding women's perceptions and concerns about COVID-19 vaccines

Large U.S. study finds majority of mRNA COVID-19 side effects are mild and temporary

Neurological complications are higher with SARS-CoV-2 infection than COVID vaccine, study finds

Areas with higher 1968 influenza pandemic mortality have lower COVID-19 deaths

The impact of SARS-CoV-2 variants on the COVID-19 epidemic in South Africa

Clinical assay validation for SARS-CoV-2 sequencing using Swift Biosciences amplicon panel

New Canadian serology solution for SARS-CoV-2 infections and vaccination

COVID-19 patients' eyes and tears can be infected with SARS-CoV-2

Exercises using virtual reality to relieve COVID breathlessness

The ability of natural flavonoids to inhibit SARS-CoV-2

Stanford neuromodulation therapy causes remission in almost 80% of patients with severe depression

Researchers receive $9.1 million grant to study resilience in older adults before and during the pandemic

U of U Health scientists lead new studies investigating the long-term effects of COVID-19

Opening schools for in-person learning not linked with increase in COVID-19 case rates

Children and adults have similar risks of SARS-CoV-2 infection, but kids do not show symptoms

Researchers explore whether salivary glands infected with SARS-CoV-2 can diminish long-term immunity

Moderna vaccine offers substantial protection against delta variant in vaccinated prisoners

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News